Gestational diabetes mellitus (GDM) is the most common metabolic complication of
pregnancy, with a prevalence that has increased significantly in the last decade, coming to …

Metabolomics is the discipline where endogenous and exogenous metabolites are
assessed, identified and quantified in different biological samples. Metabolites are crucial …

Gestational diabetes mellitus (GDM) is the fastest growing type of diabetes, affecting
between 2 to 38% of pregnancies worldwide, varying considerably depending on diagnostic …

Pregnancy presents a unique physiological challenge that requires changes coordinated by
placentally and non–placentally derived hormones to prepare the mother for the metabolic …

NMR-based metabolomics has shown considerable promise in disease diagnosis and
biomarker discovery because it allows one to nondestructively identify and quantify large …

Aims/hypothesis Antenatal obesity and associated gestational diabetes (GDM) are
increasing worldwide. While pre-existing insulin resistance is implicated in GDM in obese …

Gestational diabetes (GDM) results from failure of the β cells to adapt to increased metabolic
demands; however, the cause of GDM and the extremely high rate of progression to type 2 …

Metabolic profiles of amniotic fluid and maternal blood are sources of valuable information
about fetus development and can be potentially useful in diagnosis of pregnancy disorders …

Gestational Diabetes (GDM) is causing severe short-and long-term complications for mother,
fetus or neonate. As yet, the metabolic alterations that are specific for the development of …

Abstract Gestational Diabetes Mellitus (GDM) is a hyperglycemia state that impairs maternal
and offspring health, short and long-term. It is usually diagnosed at 24–28 weeks of …